ROCHESTER, Minn. — A Mayo Clinic-led group of researchers has discovered three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL). Findings are published in the journal Blood.
Recent Posts
- UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
- Do stem-cell transplants increase cancer risk? Long-lived recipients offer clues
- Re-engineered, blue light-activated immune cells penetrate and kill solid tumors
- Microenvironment-responsive nanomedicines: a promising direction for tissue regeneration
- Life Without Sickle Cell Beckons Boy Who Completed Gene Therapy
- Neuroscientists discover a mechanism that can reactivate dormant neural stem cells